I agree that this site is using cookies. You can find further informations here.
X
Ogata, Yutaka
346  results:
Search for persons X
?
1

Final analyses of the prospective controlled trial on the e..:

Ogata, Yutaka ; Sadahiro, Sotaro ; Sakamoto, Kazuhiro...
International Journal of Clinical Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

ABCG5 and ABCG8 Are Involved in Vitamin K Transport:

Matsuo, Michinori ; Ogata, Yutaka ; Yamanashi, Yoshihide.
Nutrients.  15 (2023)  4 - p. 998 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fa..:

Yamanashi, Yoshihide ; Takada, Tappei ; Tanaka, Yusuke...
Biomedicine & Pharmacotherapy.  156 (2022)  - p. 113877 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Prospective observational study of the efficacy of oral ura..:

Sadahiro, Sotaro ; Sakamoto, Kazuhiro ; Tsuchiya, Takashi...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Late recurrence of cancer stem cell-positive colorectal can..:

Nagano, Taichi ; Itoh, Shinji ; Miyashita, Yu...
Clinical Journal of Gastroenterology.  14 (2021)  2 - p. 613-616 , 2021
Link: https://doi.org/10.1007/..
 
?
6

An Observational Study of Team Management Approach for Cape..:

Matsuoka, Hiroshi ; Ogata, Yutaka ; Nakamura, Michio...
Journal of the Anus, Rectum and Colon.  4 (2020)  2 - p. 79-84 , 2020
Link: https://doi.org/10.23922..
 
?
7

JOIN trial: treatment outcome and recovery status of periph..:

Yoshino, Takayuki ; Kotaka, Masahito ; Shinozaki, Katsunori...
Cancer Chemotherapy and Pharmacology.  84 (2019)  6 - p. 1269-1277 , 2019
Link: https://doi.org/10.1007/..
 
?
8

Correction to: S-1 and irinotecan plus bevacizumab as secon..:

Miyamoto, Yuji ; Tsuji, Akihito ; Tanioka, Hiroaki...
International Journal of Clinical Oncology.  23 (2017)  2 - p. 402-402 , 2017
Link: https://doi.org/10.1007/..
 
?
9

S-1 and irinotecan plus bevacizumab as second-line chemothe..:

Miyamoto, Yuji ; Tsuji, Akihito ; Tanioka, Hiroaki...
International Journal of Clinical Oncology.  21 (2016)  4 - p. 705-712 , 2016
Link: https://doi.org/10.1007/..
 
?
10

A Phase II Study of Third-Line Combination Chemotherapy wit..:

Yoshida, Motoki ; Takagane, Akinori ; Miyake, Yasuhiro...
Oncology.  91 (2016)  1 - p. 24-30 , 2016
Link: https://doi.org/10.1159/..
 
?
11

Multicenter phase II study of combination therapy with cetu..:

Kyushu Study Group of Clinical Cancer (KSCC) ; Takahashi, Takao ; Emi, Yasunori...
Cancer Chemotherapy and Pharmacology.  78 (2016)  3 - p. 585-593 , 2016
Link: https://doi.org/10.1007/..
 
?
12

Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA..:

Baba, Hideo ; Baba, Yoshifumi ; Uemoto, Shinji...
Oncotarget.  6 (2015)  32 - p. 34004-34013 , 2015
Link: https://doi.org/10.18632..
 
?
13

Phase II trial of an alternating regimen consisting of firs..:

Kyushu Study Group of Clinical Cancer ; Miwa, Keisuke ; Oki, Eiji...
International Journal of Clinical Oncology.  21 (2015)  1 - p. 110-117 , 2015
Link: https://doi.org/10.1007/..
 
?
14

Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Co..:

Kyushu Study Group of Clinical Cancer (KSCC) ; Oki, Eiji ; Emi, Yasunori...
Annals of Surgical Oncology.  22 (2015)  S3 - p. 1067-1074 , 2015
Link: https://doi.org/10.1245/..
 
?
15

Treatment Rationale and Study Design for Clinical Trial on ..:

Sadahiro, Sotaro ; Morita, Satoshi ; Sasaki, Kazuaki...
Clinical Colorectal Cancer.  14 (2015)  4 - p. 277-280 , 2015
Link: https://doi.org/10.1016/..
 
1-15